JC polyomavirus mutants escape antibody-mediated neutralization.
about
In Vitro and In Vivo Models for the Study of Human Polyomavirus InfectionProgressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyType I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent MannerThe DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective.Natalizumab treatment of multiple sclerosis: new insights.Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients.Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.CD4 T cells control development and maintenance of brain-resident CD8 T cells during polyomavirus infection
P2860
Q28074684-4D2AC384-9514-47C8-A3B2-860F29AA3F7FQ30245002-89BB7CFC-0F4C-4D0F-9EA1-2A9A57E1F96FQ36764988-1E01215E-7669-441F-948A-351CFA6B6042Q36878949-FBA06E76-AFA0-4C37-A12E-85E880D690D7Q37526148-CD788C01-A1E7-4767-9BBD-70149406E5ADQ38665891-899B81A0-6DCA-4645-A065-BE6DA477B24AQ38801394-64558D99-1F18-4D7F-97FF-B21236BC856BQ39046213-00D2C114-B4F9-4A60-A558-B3DD6BFE5852Q39048568-BE4491AE-15C8-44EA-A469-EB09F6081AC3Q40761630-B72DD014-F98F-454E-B060-83E3C762A043Q41921811-0D3DF7E2-26CC-4DD6-A3E2-F44B1BFBA59BQ45325710-021BCF20-9052-47F3-BA9A-4D6CBB152FCBQ47147327-A2401736-DA9C-4A42-BF7E-FAAEE0C5BDAFQ47549901-048EA452-6539-4FB5-B8F3-B8664BD40465Q54215480-F5B4D520-B232-44DE-9150-26DC0EF26F82Q58106789-4D5BBFAA-9478-43BA-B74C-2E8D1412A96D
P2860
JC polyomavirus mutants escape antibody-mediated neutralization.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
JC polyomavirus mutants escape antibody-mediated neutralization.
@en
type
label
JC polyomavirus mutants escape antibody-mediated neutralization.
@en
prefLabel
JC polyomavirus mutants escape antibody-mediated neutralization.
@en
P2093
P2860
P50
P1476
JC polyomavirus mutants escape antibody-mediated neutralization
@en
P2093
Christopher B Buck
Paola Cinque
Simonetta Gerevini
Sven Schippling
Upasana Ray
Valeria Longo
P2860
P304
P356
10.1126/SCITRANSLMED.AAB1720
P407
P577
2015-09-23T00:00:00Z